Article
Weight-loss Medications And The Increasing Risk Of Claims
GLP-1 weight-loss medications like Wegovy, Mounjaro and Ozempic have seen explosive growth in both NHS and private healthcare settings, with over four million prescriptions dispensed in 2025/26 alone. As millions more UK adults plan to start treatment and online providers proliferate, healthcare professionals face mounting exposure to clinical negligence claims arising from inadequate assessment, consent processes, and patient monitoring. What are the key risk factors driving potential litigation, and how c
Brechin Tindal Oatts